COVID-19 Biopharmaceutical Innovation and Industry Appropriation

by | Apr 25, 2024

The rapid emergence of vaccines and therapeutics in response to the onset of the coronavirus (COVID-19) pandemic demonstrated the value of medical innovation. These advances not only led to enhanced patient welfare by reducing the disease’s mortality and morbidity but...

Prices and Federal Policies in Opioid Markets | October 2022

by | Oct 1, 2022

Consumer theory is extended to incorporate deviations from the law of one price that are common in markets for prescription and illicitly-manufactured opioids. The extension helps to resolve “puzzling” findings in the literature, such as race and age gaps in mortality...
Scroll to Top